,Name of Issuer,Title of Class,CUSIP,Value,SHRS OR SH,PRN AMT PRN,Investment Discretion,Voting Authority_Sole,Voting Authority_Shared,Voting Authority_None,Date,Period,Filing Manager,CIK
0,ABBVIE INC.,COM,00287Y109,94,1000,SH,SOLE,1000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
1,ALLERGAN PLC,SHS,G0177J108,65525,344000,SH,SOLE,344000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
2,BIOGEN INC.,COM,09062X103,163179,461858,SH,SOLE,461858,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
3,INNOVIVA INC.,COM,45781M101,69113,4535000,SH,SOLE,4535000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
4,INTERCEPT PHARMACEUTICALS INC.,COM,45845P108,32537,257500,SH,SOLE,257500,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
5,IRONWOOD PHARMACEUTICALS INC.,COM CL A,46333X108,62156,3367100,SH,SOLE,3367100,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
6,MEDICINES CO.,COM,584688105,57487,1922000,SH,SOLE,1922000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
7,NOVELION THERAPEUTICS INC.,COM NEW,67001K202,3034,1025000,SH,SOLE,1025000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
8,SHIRE PLC,SPONSORED ADR,82481R106,181,1000,SH,SOLE,1000,0,0,2018-09-30,2018Q3,Sarissa Capital Management LP,0001577524
